Biotechnology has emerged as an important sector, and is poised to grow in future as well. Find all the latest information and trends on biotechnology stocks at Profit Confidential.
Over the past five years, investor money is increasingly moving towards consumer software and later-stage life science ventures, a trend that could help develop new treatments.
After three years of rip-roaring returns, here's how the manager of the Fidelity Select Biotechnology Fund (FBIOX) is finding value and avoiding froth.
Biotechnology has emerged as an important sector, and is poised to grow in future as well. Find all the latest information and trends on biotechnology stocks at Profit Confidential.
Over the past five years, investor money is increasingly moving towards consumer software and later-stage life science ventures, a trend that could help develop new treatments.
After three years of rip-roaring returns, here's how the manager of the Fidelity Select Biotechnology Fund (FBIOX) is finding value and avoiding froth.
